Benchling Stock
Benchling Inc. develops an integrated software solution for experiment design, note-taking, and molecular biology. The company offers Benchling, a research platform that allows scientists to design, share, and record experiments on one interface. Benchling's platform consists of an integrated lab notebook, biological registration system to track inventory, such as plasmids, antibodies, and cell strains, and molecular biology design and analysis suite that streamlines research and development.
Sign up today for more details and to buy or sell Benchling Stock
Buy + SellSee Valuations and Financials
Gain insights Into Benchling Stock Valuation + Share Prices
Get started to view real-time data on Benchling stock including most recent valuation and historical share price information.
Get StartedBenchling Management Team
Co-Founder, CEO, Director
Sajith Wickramasekara
Co-Founder, President, Director
Ashutosh Singal
CFO, Director
Ron Gill
Head of Security
Zach Powers
General Counsel
Ricardo Velez
President of Field Operations
Paul Robson
Director
Jennifer Goldsmith
Director
Miles Grimshaw
Director
Eric Vishria
Director
Krist Anderson-Copperman
Director
Elena Donio
Benchling Major Investors
Alkeon Capital
Altimeter Capital Management LLC
Andreessen Horowitz LLC; AKA: A16Z
Benchmark Capital
Byers Capital
F-Prime Capital Partners
Franklin Templeton
Lead Edge Capital
Lone Pine Capital
Lux Capital
Menlo Ventures
Sequoia Global Equities
Spark Capital Partners LLC
Thrive Capital Partners LLC
Tiger Global Management LLC
Y Combinator